Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

Status unconfirmed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Psychological Stress, Hypertension, Renal

In brief

The purpose of this study is to determine if stopping the stress induced increase in inflammation will prevent sodium retention which in turn increases blood pressure. Each subject will test two separate times. One week, they will be taking a daily dose of mycophenolate mofetil (MMF), the other week they will be taking a placebo.

Key facts

Study ID

NCT02432339

Run by

Augusta University

People needed

50

Starts

2014-04-22

Expected to finish

2019-11-30

Last updated by the study team

2019-06-20

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• African American
• Not pregnant or breastfeeding
• Does not have high blood pressure
• Currently not taking any medications that may effect blood pressure

You may not qualify if…

• Pregnant or breastfeeding
• Has High Blood pressure
• Taking medication that may effect blood pressure
• Failed Screening blood sample lab results - reviewed by study designated doctor

Where it is running

• Augusta University — Augusta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.